Purpose: To show early, rapid and accurate molecular diagnosis of occult macular dystrophy (OMD) in a four-generation Chinese family with inherited macular dystrophy.
INTRODUCTION
Occult macular dystrophy (OMD) is an unusual, inherited or sporadic macular dystrophy characterized by an almost normal-appearing fundus and fluorescein angiography, with aggressive decreases in binocular visual acuity (BCVA) (Miyake et al., 1996) . The age of onset varied from 6 to 81 years old (Akahori et al., 2010) . OMD patients show normal full-field electroretinograms (ERGs), but a markedly decline in macular responses in multifocal ERG (Tsunoda et al., 2012; Nakanishi et al., 2015) . Photoreceptor and outer nuclear layer (ONL) abnormalities are the main pathologic changes in OMD; thus spectral domain optical coherence tomography (SD-OCT) and mfERG are considered the best assessments for clinical diagnoses (Park et al., 2010; Ahn et al., 2013; Sisk and Leng, 2014; Nakanishi et al., 2015) . However, these diagnostic tools are time consuming and require both equipment and resources. In addition, patients with poor fixation due to low vision or patients who are too young to cooperate with visual testing often show variable results on mfERG. Moreover, due to the clinical heterogeneity of retinal diseases, fast and accurate diagnosis and identification are often difficult. Most importantly, early-stage OMD, with no visual impairment exhibits phenotypic overlap with numerous retinal diseases, such as cone-rod dystrophy, early changes in agerelated macular degeneration and Stargardt's disease (SD) (Pang and Lam, 2002) , and is not easily detected. Therefore, genetic diagnosis is an essential first step for the early diagnosis and confirmation of OMD. Genetic testing is extremely curial for genetic counseling, risk assessment, individualized therapy and carrier screening of OMD patients and their family members. With the advent of precision medicine and gene diagnosis technology, a thorough description of any patient's disease should include both genetic and clinical information (Ashley, 2015; Barlas, 2015; Collins and Varmus, 2015; Ghitza, 2015) .
The hereditary mode of OMD is autosomal dominant in numerous patients and sporadic in others (Akahori et al., 2010; Davidson et al., 2013) . The RP1-like protein 1 (RP1L1) gene (OMIM 608581) is the gene most commonly associated with OMD (Davidson et al., 2013) , and many mutations in RP1L1 have been reported, such as p.Arg45Trp (Akahori et al., 2010; Hayashi et al., 2012; Tsunoda et al., 2012; Ahn et al., 2013; Okuno et al., 2013) , p.S1199P (Takahashi et al., 2014) , p.S1199C (Kabuto et al., 2012) , p.W960R (Akahori et al., 2010) , p.Q2311P (Ahn et al., 2013) , and p.S676C (Ahn et al., 2013) . The most frequent mutation is p.Arg45Trp in exon 2. However, p.Arg45Trp is involved in only approximately 37% of Korean, white European and British OMD cases (Akahori et al., 2010; Ahn et al., 2013; Davidson et al., 2013) . Davidson et al. (2013) suggested that the Arg45Trp mutation is a risk factor, not a causative mutation, for OMD. Therefore, OMD is considered to be a genetically heterogeneous disease.
In view of the substantial clinical and genetic complexity underlying OMD, molecular diagnosis is an effective supplementary diagnosis method. In this study, we performed molecular diagnosis of a four-generation Chinese family by next-generation sequencing (NGS)-based target captures sequencing and a complete ophthalmological examination. Two heterozygous mutations-RP1L1 c.133 C > T (p.Arg45Trp) and ATP-binding cassette transporter 4 (ABCA4) c.6119G > A (p.Arg2040Gln) were identified in three patients, including individuals with normal vision. These results cannot only confirm and provide presymptomatic diagnosis and detection of OMD but also expand our knowledge of genotype-phenotype correlations and emphasizes the significance of molecular diagnosis and genetic counseling for OMD.
MATERIALS AND METHODS

Subjects and Ethics Statement
The current study was performed in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for medical research involving human subjects and was approved by the Ethics Committee of the Eye and ENT Hospital of Fudan University. Written informed consent was obtained from all participants or their guardians.
Clinical Evaluations and Sample Collection
Our study involved seven family members from four generation, who underwent detailed history ophthalmic examination, including BCVA testing, color vision (Ishihara color plate), slit lamp biomicroscopy, tonometry (Humphrey VisualField Analyzer, Carl Zeiss, Inc., Dublin, CA, United States), dilated fundus examination, SD-OCT (Spectralis HRA + OCT, Heidelberg, Engineering, Inc., Heidelberg, Germany), OCT angiography (OCTA), visual field tests with RTVue XR Avanti OCT with AngioVue (Optovue, Fremont, CA, United States), fundus autofluorescence (FAF, Spectralis HRA +OCT; Heidelberg, Germany), full-field ERG and multifocal ERG (mfERG, LKC UTAS E3000 LKC Technologies, Inc., United States). We also examined 256 normal control volunteers from China, with a normal phenotype in visual acuity testing and visual field measurement and no other obvious serious diseases. Family and medical history, including subjective degree of vision loss, age of onset and other related clinical manifestations, was obtained. Blood samples were collected from the peripheral blood and stored at 4 • C before further analysis.
Genetic Analyses
Genomic DNA from the family was extracted from the peripheral blood on April 25, 2016 using a standard method (Ma et al., 2015) . The proband was analyzed first; we designed a high-throughput microarray with exon-capture and NGS targeting of the 130 genes that are most frequently involved in common inherited nonsyndromic eye diseases (the capture probes were custom designed and produced by BGI, Supplementary Table S2 ). Then, library preparation, qualification, and NGS of the targeted sequences were further conducted on an Illumina Hiseq 2000 platform (Illumina, Inc., San Diego, CA, United States) in collaboration with BGI-Shenzhen (Shenzhen, Guangdong, China) as detailed previously (Chen et al., 2013 (Chen et al., , 2015 . The following 5 databases were then used for annotation of all identified variants with minor allele frequency (MAF) > 0.1% to eliminate benign variants: dbSNP137 1 , HapMap Project 2 , 1000 Genomes Project 3 , YH database 4 , and Exome Variant Server 5 . Finally, the variant prioritizations were performed, combining total depth, quality score, MAF, potential deleterious effect and the existence of mutation reports in common databases such as the Human Gene Mutation Database (HGMD), Retinal Information Network (RetNet), ClinVar or Online Mendelian Inheritance in Man (OMIM). For variants that passed the initial filtration, we used Sanger sequencing for verification of variants within other family members and 256 normal control volunteers. Sanger sequencing was conducted as previously described (Zhao et al., 2006) . Evolutionary conservation of the mutations was performed online 6 .
RESULTS
Clinical Examination and Pedigree Analysis
A total of 256 normal control volunteers and seven members from a four-generation family were included in this study. The clinical characteristics of the four affected family members are listed in Table 1 . The proband (P5), a 38-year-old man, has suffered from a progressive decrease in visual acuity in both eyes over 10 years without a definite diagnosis. Ophthalmic examinations revealed a BCVA of 0.5 (OD:1.50 DS; OS:0.25 DS) in both eyes. Intraocular pressure (IOP) was 11 mm Hg in the right eye and 12 mm Hg in the left eye. The proband's anterior segments and media examination were unremarkable. His fundus ( Figure 1A ) and visual field (data not shown) revealed no abnormalities, while FAF demonstrated a faint hyperfluorescent ring resembling a bull's eye ( Figure 1B) . Scotopic and photopic full-field ERGs showed normal responses ( Figure 1E ), while mfERG showed that the amplitudes in the rings 1-3 of both eyes were significantly reduced, with the right eye more seriously affected ( Figures 1F,G) , indicating dysfunction of the central retina (Fujii et al., 1999; Piao et al., 2000) . SD-OCT revealed disruption of the interdigitation and ellipsoid zones at the fovea, but both were still visible in the perimacular region ( Figure 2C ). For further observation of retinal perfusion in the macular region, OCTA was performed on P5 and P7 ( Figures 3A,B) , the data were set to flatten the inner limiting membrane (ILM), inner plexiform layer (IPL), and retinal pigment epithelium (RPE) from the inner to outer retina, and no aberrant vascular networks were 6 http://www.bioinformatics.org/strap/index2
detected. The fundus (Figure 1C) , FAF (Figure 1D ), SD-OCT ( Figure 2D ) and OCTA ( Figure 3B ) results from P7, a 9-year-old patient, whose BCVA was 1.0 in both eyes, were similar to those from P5. Eight months later, the BCVA of P7 began to decrease (0.8 in both eyes). The proband's father (P3), who was 62 years old, had a BCVA of 0.6 in the right eye and 0.8 in the left. SD-OCT showed that the retinal thickness and structures in both the fovea and the perimacular region were normal (Figure 2A ), but severely damaged in P4 (Figure 2B ), whose BCVA was 0.08 in both eyes. P4 is the proband's mother, 63-year -old, she suffered from vision problems when she was 30 years old. The detailed clinical characteristics of P3, P4, P5, P7 are listed in Table 1 .
Genetic Analyses
We performed a targeted NGS approach on the proband (P5). The targeted gene length was 514,593 bp and the mean depth of target region was 187.67 X, with 99.61% coverage. After the data acquisition and analysis, an average of 169 raw variants were initially obtained ( Supplementary Table S1 ). Finally, by further bioinformatics analysis, two missense mutation c.133 C > T in the RP1L1 gene (Akahori et al., 2010; Ahn et al., 2013; Davidson et al., 2013) and c.6119 G > A in the ABCA4 gene (Xu et al., 2014; Zernant et al., 2014; Jiang et al., 2016) were identified as potentially pathogenic mutations ( Table 2 and Figure 4B ). These mutations, c.133 C > T and c.6119 G > A, were extremely rare in the control population, with a frequency of 0.0009 and 0 in 1000 Genomes Project, respectively. Moreover, the mean occurrence frequency of the two mutations in the SNV database of over 200 Chinese individuals was less than 0.01. Further analysis using PolyPhen-2 and SIFT predicted that both mutations were pathogenic. Sanger sequencing was then performed to validate the variant in the studied family and the 256 normal control individuals. The proband's mother (P4) and his son (P7) carried the two mutations in the heterozygous state, but the mutations were not found in his father or the 256 unrelated healthy individuals, who were phenotypically normal (P3, Figure 4A ). Multiple orthologous sequence alignment (MSA) revealed that codon 2040 of ABCA4 and its subsequent sequences were highly conserved amino acids across different species (Figure 5A) , suggesting that mutations of those codons may lead to a deleterious effect. The RP1L1 c.133 C > T mutation was not conserved in the nine species analyzed in this study ( Figure 5B) . 
. Amplitudes in the rings 1-3 of both eyes were significantly reduced, with the right eye more seriously affected.
DISCUSSION
Next-generation sequencing, which greatly intensely enhanced sequencing output with lower costs, is a high-throughput approach capable of efficiently sequencing large gene pools. NGS has enabled the identification of many rare disease genes (Roosing et al., 2013) . Therefore, NGS has become a powerful tool for elucidating comprehensive mutation profiles
Frontiers in Genetics | www.frontiersin.org for heterogeneous diseases (Coppieters et al., 2014) , including OMD. In this study, we comprehensively screened 130 genes involved in common, inherited, non-syndromic eye diseases and successfully identified 2 potentially causative mutations for OMD, c.133 C > T in the RP1L1 gene and c.6119 G > A in the ABCA4 gene. Based on the mutation analysis and the clinical assessment, we concluded that OMD is the exact diagnosis of the three members (P4, P5, P7) of the studied family. The human RP1L1 gene, spanning 50 kb on chromosome 8p, is encoded in four exons. RP1L1 has the highest sequence similarity to retinitis pigmentosa 1 (RP1 OMIM * 603937), with 48% identity and 61% similarity between the human and mouse sequences (Bowne et al., 2003; Conte et al., 2003) . The length of RP1L1 mRNA is over 7 kb, whereas the specific length is varies across individuals as a result of the presence of several length polymorphisms. The predicted molecular weight of the protein, encoded by RP1L1 and with a minimal length of 2,400 amino acids, is predicted 252 kDa (Bowne et al., 2003) . Immunohistochemistry shows that retina RP1L1 is present only in the retina, and localized to the connecting cilium of rod and cone photoreceptors, indicating a pathogenic function for the RP1L1 mutation in OMD photoreceptor disturbances (Bowne et al., 2003; Akahori et al., 2010; Davidson et al., 2013; Takahashi et al., 2014) . Amino acids 33-113 and 147-228, where the RP1L1 p.Arg45Trp alteration resides, can interact with RP1 to assemble and stabilize axonemal microtubules (Yamashita et al., 2009) . Dominant mutations in RP1L1 p.Arg45Trp were first reported in all affected individuals from three Japanese families with OMD (Akahori et al., 2010) , but only four candidate genes were studied. Later, Seong Joon Ahn found that RP1L1 p.Arg45Trp is involved in 36.8% of Korean OMD cases (Ahn et al., 2013) , while different RP1L1 mutations account for other cases. However, Ahn colleagues sequenced only the entire exons and flanking regions of the RP1L1 gene in 19 Korean patients with OMD. Thus, the abovementioned studies cannot rule out the possibility of other mutations. Further genetic studies on more candidate genes with a larger population samples are needed. MSA revealed that RP1L1 p.Arg45Trp is not conserved in the nine species analyzed in this study. This finding is consistent with previous studies showing that the RP1L1 p.Arg45Trp variant may represent a risk factor for OMD rather than a causative mutation. Therefore, other causative genes may coexist.
The photoreceptor-specific ABCA4 gene is localized at the rims of the outer segments of cone and rod photoreceptors, where it exclusively encodes a transmembrane protein exclusively (Papermaster et al., 1976; Cideciyan et al., 2009) . As an active transporter of all trans-retinal (atRAL), ABCA4 can flip N-retinylidene-phosphatidylethanolamine from the extracellular to cytoplasmic leaflet of internal disk membranes within photoreceptor outer segments (Tsybovsky et al., 2013) . Mutations in ABCA4 lead to the accumulation of toxic bisretinoid atRAL adducts of atRAL in photoreceptors and RPE (Cideciyan et al., 2015) , and reduced BCVA reduced as the disease process is initiated near the center of the macula (Cideciyan et al., 2005; Huang et al., 2014) . ABCA4 mutations are one of the most frequent monogenetic pathogenesis for retinal degeneration (Cideciyan et al., 2009 (Cideciyan et al., , 2012 Zangerl et al., 2010; Fujinami et al., 2013) . The clinical manifestation of ABCA4-related retinopathy is variable, including autosomal recessive Stargardt's disease (arSTGD), fundus flavimaculatus, autosomal recessive cone-rod dystrophy (arCRD) and autosomal RP (Jaakson et al., 2003; Valverde et al., 2007; Riveiro-Alvarez et al., 2013; Jiang et al., 2016) . However, whether ABCA4 also plays a role in OMD is unknown. In this study, the proband has suffered from maculopathy without a definitive diagnosis for over 10 years, and his son was unaware of his visual abnormalities. Through mutation analysis, combined with clinical history and examination, we achieved an accurate molecular diagnosis of OMD in three family members carrying RP1L1 p.Arg45Trp mutations in the family. Dominant mutations in the RP1L1 gene were involved in100% of OMD cases in the current study and presumably arose for three reasons. First, genetic backgrounds or even nongenetic factors may affect the phenotypes of individuals with RP1L1 variants, which has been proposed in previous studies. Consistent with this idea, significant phenotypic distinction has been detected in OMD patients, though with the same causative alleles in the same family (Tsunoda et al., 2012; Ahn et al., 2013) . Moreover, in this study, the age of onset, disease progression and disease manifestations varied across the three patients. However, we cannot rule out the possibility that with increasing age and disease progression, visual performance may become similar across family members. Second, other causative genes may exist. Studies in Japanese have suggested that OMD is not a single disease caused by a specific gene mutation, such as RP1L1 (Tsunoda et al., 2012) . In the present study, we also found a heterozygous mutation c.6119 G > A in the ABCA4 gene; therefore, we hypothesize that the RP1L1 p.Arg45Trp or ABCA4 p.Arg2040Gln mutations affects only part of the transcribed mRNA, and a certain amount of RP1L1 or ABCA4 protein is still sufficient to sustain proper cell function. When the two mutations are present simultaneously, abnormal protein may accumulates in cone and rod photoreceptors, or the two proteins or genes may interact, eventually leading to OMD. Our results are consistent with previous reports that the Arg45Trp mutation is a risk factor for OMD rather than a causative mutation (Piermarocchi et al., 2016) . However, there may be other unknown mechanisms responsible for the observed phenotype, and further in-depth studies involving more family members and normal controls are needed.
CONCLUSION
To the best of our knowledge, this study used the first NGSbased assay specifically designed for the confirmation and early diagnosis of OMD in a Chinese pedigree reported to date. In addition, we found that heterozygous mutations of RP1L1 c.133 C > T (p.Arg45Trp) and ABCA4 c.6119 G > A (p.Arg2040Gln) are likely responsible for OMD; this OMD genetic mutation pattern is novel, and the functions and interactions of RP1L1 and ABCA4 should be further investigated. This study not only provides a guide to the attending clinician on the management and prognosis of the patient, but also extends the phenotypic spectrum of RP1L1-associated OMD and enhances our current understanding of the genetic basis of OMD.
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